| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ELVN | Enliven Therapeutics, Inc. | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Apr 11, 2024 | Sale | $13.60 | 28,000 | 380,869 | 14,000 | Apr 15, 2024, 07:04 PM | |
| ELVN | Enliven Therapeutics, Inc. | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Mar 27, 2024 | Sale | $10.36 | 6,500 | 67,362 | 3,250 | Mar 29, 2024, 05:59 PM | |
| ELVN | Enliven Therapeutics, Inc. | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Feb 27, 2024 | Option Exercise | $9.73 | 6,500 | 63,223 | 3,250 | Feb 29, 2024, 05:27 PM | |
| ELVN | Enliven Therapeutics, Inc. | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Jan 29, 2024 | Option Exercise | $9.15 | 6,500 | 59,448 | 3,250 | Jan 31, 2024, 09:20 PM | |
| ELVN | Enliven Therapeutics, Inc. | Hohl Benjamin | Chief Financial Officer | Dec 28, 2023 | Sale | $8.78 | 4,934 | 43,306 | 2,467 | Jan 02, 2024, 07:59 PM | |
| ELVN | Enliven Therapeutics, Inc. | Hohl Benjamin | Chief Financial Officer | Dec 29, 2023 | Sale | $8.74 | 40 | 350 | 20 | Jan 02, 2024, 07:59 PM | |
| ELVN | Enliven Therapeutics, Inc. | Hohl Benjamin | Chief Financial Officer | Jan 02, 2024 | Option Exercise | $8.75 | 18,766 | 164,109 | 9,383 | Jan 02, 2024, 07:59 PM | |
| ELVN | Enliven Therapeutics, Inc. | Hohl Benjamin | Chief Financial Officer | Dec 22, 2023 | Sale | $8.78 | 2,060 | 18,079 | 1,030 | Dec 27, 2023, 05:26 PM | |
| ELVN | Enliven Therapeutics, Inc. | Hohl Benjamin | Chief Financial Officer | Dec 26, 2023 | Sale | $8.74 | 200 | 1,748 | 100 | Dec 27, 2023, 05:26 PM |
Menu